What is the recommended Mebendazole (anti-parasitic medication) dose for a 13-month-old child requiring deworming treatment?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Mebendazole Should NOT Be Given to a 13-Month-Old Child

Mebendazole is contraindicated in infants under 12 months of age, and a 13-month-old child is at the borderline where extreme caution is warranted. The CDC explicitly advises against administering mebendazole to infants under 12 months 1. Given that your patient is only 1 month past this cutoff, I would strongly recommend using albendazole as the safer alternative.

Recommended Treatment Approach

First-Line: Albendazole (Preferred for This Age)

  • Dose: 400 mg as a single oral dose 2
  • Repeat the same dose in 2 weeks to eradicate newly hatched worms 2
  • This dose is standardized across all pediatric age groups, including very young children 2
  • Albendazole has better safety data in children just over 1 year of age 2

If Mebendazole Must Be Used (Second-Line)

If albendazole is unavailable and you must use mebendazole:

  • Dose: 100 mg twice daily for 3 days 1
  • For a child weighing approximately 10-11 kg (typical for 13 months), this represents the standard pediatric dose 1
  • The tablets should be chewed for optimal absorption 1
  • Repeat the full 3-day course in 2 weeks 3

Important Clinical Considerations

Age-Related Safety Concerns

  • The hard contraindication at <12 months exists due to limited safety data in very young infants 1
  • At 13 months, the child has just crossed this threshold, making albendazole the more conservative choice 2
  • Monitor for hepatotoxicity and leukopenia if treatment extends beyond 14 days, though this is rare with standard deworming courses 2

Parasite-Specific Dosing

The treatment regimen varies by parasite type:

  • Pinworm (Enterobius): Single dose of 100 mg, repeat in 2 weeks 3
  • Roundworm (Ascaris): 100 mg twice daily for 3 days OR single 500 mg dose 1
  • Whipworm (Trichuris): 100 mg twice daily for 3 days 1, 3

Common Pitfalls to Avoid

  • Do not use single-dose regimens for mixed infections - the 3-day course is more effective for multiple parasite species 4
  • Ensure proper tablet administration - tablets must be chewed, not swallowed whole, for optimal absorption 1
  • Anticipate mild diarrhea - occurs in approximately 22% of children and is self-limited 4
  • Plan for retreatment - persistent symptoms after 2-4 weeks usually indicate reinfection, not treatment failure 2

Monitoring and Follow-Up

  • Symptoms (particularly nocturnal perianal itching for pinworms) should improve within 2-4 weeks 2
  • If symptoms persist beyond this timeframe, consider reinfection rather than medication resistance 2
  • In high-transmission areas, reinfection rates can return to baseline by 12-16 weeks, necessitating repeat treatment 5

Why Albendazole Is Preferred at This Age

  • Broader safety margin in children just over 12 months 2
  • Single-dose convenience improves adherence compared to 3-day mebendazole course 2
  • Equal efficacy to mebendazole for most common helminth infections 2
  • WHO-recommended for mass deworming programs in children over 1 year 1

References

Guideline

Mebendazole Treatment Guidelines for Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Pinworm Treatment Guidelines for Young Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Helminth Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Efficacy and safety of mebendazole in children with worm infestation.

JPMA. The Journal of the Pakistan Medical Association, 1997

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.